Exploratory analysis of long-term suppressive therapy with dalbavancin in ventricular assist device infections caused by Staphylococcus aureus

Exploratory analysis of long-term suppressive therapy with dalbavancin in ventricular assist device infections caused by Staphylococcus aureus

Abstract To analyze dalbavancin’s potential for long-term suppressive therapy in patients with infected ventricular assist devices (VAD), the VAD register of Heidelberg University Hospital was searched for patients who received dalbavancin for long-term suppression therapy. Clinical data, laboratory...

Full description

Saved in:
Bibliographic Details
Main Authors: Benedict Morath, Sabrina Klein, Ute Chiriac, Yvonne Müller, Lisa Koeppel, Otto Frey, Heike Lanzinger, Philipp Schlegel, Sonja Hamed, Dennis Nurjadi, Philipp Ehlermann, Matthias Karck, Anna L. Meyer
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Dalbavancin
Ventricular assist device
Staphylococcus aureus
Persistent infection
Online Access:https://doi.org/10.1038/s41598-025-99112-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-99112-7

Similar Items